OCTOBER 20, 2023

Long-Acting Lipoglycopeptides: Agents With Potential in Serious Gram-Positive Infections Requiring Long-Term Therapy

By Yusuf Garwan, PharmD Candidate; David Wallace, PharmD Candidate; Taylor Morrisette, PharmD, MPH
image

Gram-positive organisms, including drug-resistant strains, are responsible for several life-threatening infections.1 The CDC lists methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) species as serious public health threats with an estimated 375,000 cases occurring each year in US hospitalized patients, leading to more than